Your browser doesn't support javascript.
loading
Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trial.
Wetzel, Julia; Pilz, Stefan; Grübler, Martin R; Fahrleitner-Pammer, Astrid; Dimai, Hans P; von Lewinski, Dirk; Kolesnik, Ewald; Perl, Sabine; Trummer, Christian; Schwetz, Verena; Meinitzer, Andreas; Belyavskiy, Evgeny; Völkl, Jakob; Catena, Cristiana; Brandenburg, Vincent; März, Winfried; Pieske, Burkert; Brussee, Helmut; Tomaschitz, Andreas; Verheyen, Nicolas D.
Afiliação
  • Wetzel J; Department of Anesthesiology, University Hospital of the RWTH Aachen, Aachen, Germany.
  • Pilz S; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Grübler MR; Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VU University Medical Centre, Amsterdam, The Netherlands.
  • Fahrleitner-Pammer A; Swiss Cardiovascular Center Bern, Department of Cardiology, Bern University Hospital, Bern, Switzerland.
  • Dimai HP; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • von Lewinski D; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Kolesnik E; Department of Cardiology, Medical University Graz, Graz, Austria.
  • Perl S; Department of Cardiology, Medical University Graz, Graz, Austria.
  • Trummer C; Department of Cardiology, Medical University Graz, Graz, Austria.
  • Schwetz V; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Meinitzer A; Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
  • Belyavskiy E; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Völkl J; Department of Cardiology, Campus Virchow, Charité University, Berlin, Germany.
  • Catena C; Department of Cardiology, Campus Virchow, Charité University, Berlin, Germany.
  • Brandenburg V; Hypertension Unit, Internal Medicine, Department of Experimental and Clinical Medical Sciences, University of Udine, Udine, Italy.
  • März W; Department of Cardiology, University Hospital of the RWTH Aachen, Aachen, Germany.
  • Pieske B; Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
  • Brussee H; Synlab Academy, Synlab Services GmbH, Mannheim, Germany.
  • Tomaschitz A; Medical Clinic V (Nephrology, Hypertensiology, Endocrinology, Diabetolgy, and Rheumatology), Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany.
  • Verheyen ND; Department of Cardiology, Medical University Graz, Graz, Austria.
J Clin Hypertens (Greenwich) ; 19(11): 1173-1180, 2017 Nov.
Article em En | MEDLINE | ID: mdl-28834128

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hormônio Paratireóideo / Doenças Cardiovasculares / Hiperparatireoidismo Primário / Análise de Onda de Pulso / Ventrículos do Coração / Hipertensão / Anti-Hipertensivos Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hormônio Paratireóideo / Doenças Cardiovasculares / Hiperparatireoidismo Primário / Análise de Onda de Pulso / Ventrículos do Coração / Hipertensão / Anti-Hipertensivos Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article